Find and Pitch Jounalists, Get Your Story Covered

Tags: selenium gastric bypass endocrinology remission weight loss

	Profile	Recent Articles on Subject
1	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Pushing Toward Asthma Remission With New Endpoints, Imaging Advances - 12 days ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 5 months ago Positive Results for Odronextamab in Relapsed/Refractory DLBCL - 11 months ago "I'm Doing Great, So When Can I Stop My Atopic Dermatitis Treatment?" - 12 months ago A Novel Mechanism of Action in Treating Relapsing MS - about 1 year ago New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks - about 1 year ago New Data on CD40 Ligand Inhibitor for Relapsing MS - about 1 year ago Multiple Sclerosis: Paving the Way to a Cure - about 1 year ago MS Treatment-Discontinuation Study Terminated After Disease Activity Returns - about 1 year ago
2	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - about 1 month ago Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 8 months ago Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard of Care Regimen for Previously Untreated CLL - 12 months ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - about 2 months ago Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers - 3 months ago A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 9 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 9 months ago Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC - 11 months ago Axatilimab Shows Efficacy in Recurrent/Refractory GVHD - 12 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - 12 months ago RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC - about 1 year ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - about 1 year ago
4	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Novel Agent Reduces Monthly Migraine Days - 3 months ago BTK Inhibitor Reduces Brain Lesions in Relapsing MS - about 1 year ago
5	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 3 months ago Another Study Backs Treatment for Preclinical Rheumatoid Arthritis - 9 months ago
6	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	RHB-104 Plus Standard of Care Offers Extended Treatment for Crohn Disease - 4 months ago Dramatic Tumor Regression Was Displayed in New Approach to CAR T Therapy - 8 months ago FDA Approves Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder - 8 months ago FDA Grants Breakthrough Device Designation for Neuroimmune Modulation Platform To Treat MS - 8 months ago Researchers Announce Positive Trial Data for the Use of Remibrutinib In Chronic Spontaneous Urticaria - 12 months ago Treatment With Anifrolumab-fnia Shows Promising Rates of Remission for Lupus - about 1 year ago Esketamine in Combination with Oral Antidepressant Could Aid Treatment-Resistant Depression - about 1 year ago Study Finds Obesity Remission Rates Are Lower Than Overweight Remission Rates in Children - about 1 year ago
7	Kristen Monaco MedPage Today	Antidepressant Discontinuation; Gun Suicide Prevention; REM Disorder Breakthrough - 5 months ago FDA Approves First-Ever Drug for Serious Liver Condition - 8 months ago T2D Remission Common With Gastric Bypass; Selenium for Hashimoto's; Cereal Chemicals - 9 months ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Study: Only 40% of Adults With Childhood Asthma Experience Remission - 8 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 12 months ago Subcutaneous Lecanemab Demonstrates Greater Amyloid Plaque Removal Than Intravenous Lecanemab - about 1 year ago
9	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	Risankizumab Significantly Reduces Severity of Psoriasis Symptoms - 8 months ago
10	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Madrigal wins first U.S. approval for drug to treat liver disease MASH - 8 months ago STAT+: First medicine developed to treat MASH expected to be approved soon - 9 months ago

Journalists covering remission